研究抗体和试剂市场规模、份额及成长分析（按类型、应用、研究领域、最终用户、分销管道和地区）－2025-2032 年产业预测

预计 2023 年全球研究抗体和试剂市场价值将达到 133 亿美元，并从 2024 年的 142.2 亿美元增长到 2032 年的 242.5 亿美元，预测期内（2025-2032 年）的复合年增长率为 6.9%。

研究抗体和试剂市场正在崛起，这得益于对可重复研究至关重要的高品质抗体的需求不断增长。关键成长要素包括蛋白质体学和基因组学的扩展、旨在改善诊断和治疗结果的研发活动的活性化以及产学研合作的加强。此外，商业和非营利组织的投资增加、对生物标誌物发现的关注度增加以及政府的支持也在推动市场成长。向个人化医疗和蛋白质疗法的转变提供了进一步的有利可图的机会。然而，耗时的抗体开发和定价压力等挑战，以及对品质和可重复性的新兴担忧，可能会阻碍进展，需要在预测期内解决。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 定价分析

研究抗体和试剂市场规模（按类型和复合年增长率）（2025-2032）

• 市场概览
• 抗体
  • 产品
  • 一抗
  • 二抗
  • 来源
  • 老鼠
  • 兔子
  • 山羊
  • 老鼠
  • 其他的
  • 起源
  • 单株抗体
  • 多株抗体
  • 重组抗体
• 试剂
  • 缓衝液和溶液
  • PBS（磷酸盐缓衝生理食盐水）
  • 封闭缓衝液
  • 稀释缓衝液
  • 清洗缓衝液
  • 化学冷光试剂

研究抗体和试剂市场规模（按应用和复合年增长率）（2025-2032）

• 市场概览
• 酵素免疫分析法
• 蛋白质印迹法
• 免疫组织化学
• 流式细胞技术
• 聚合酵素链锁反应
• 其他的

研究抗体和试剂市场规模（按研究领域和复合年增长率）（2025-2032）

• 市场概览
• 免疫学
• 细胞与分子生物学
• 神经科学
• 基因组学和蛋白​​质组学
• 生物技术与药物研发
• 微生物学
• 其他的

研究抗体和试剂市场规模（按最终用户和复合年增长率划分）（2025-2032）

• 市场概览
• 製药和生物製药製造商
• 学术研究所
• 合约研究组织（CRO）
• 医院和诊断实验室
• 其他的

研究抗体和试剂市场规模（按分销管道和复合年增长率）（2025-2032）

• 市场概览
• 直销
• 第三方销售
• 其他的

研究抗体和试剂市场规模（按地区及复合年增长率）（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Thermo Fisher Scientific, Inc.（USA）
• Merck KGaA（Germany）
• Danaher Corporation（USA）
• Bio-Rad Laboratories, Inc.（USA）
• Abcam plc（UK）
• Cell Signaling Technology, Inc.（USA）
• Bio-Techne Corporation（USA）
• F. Hoffmann-La Roche AG（Switzerland）
• Agilent Technologies, Inc.（USA）
• Illumina, Inc.（USA）
• Becton, Dickinson and Company（BD）（USA）
• Proteintech Group, Inc.（USA）
• Jackson Immuno Research Inc.（USA）
• GenScript Biotech Corporation（China）
• Lonza Group Ltd.（Switzerland）
• Santa Cruz Biotechnology, Inc.（USA）
• PerkinElmer, Inc.（USA）
• Revvity（USA）
• Atlas Antibodies AB（Sweden）
• SouthernBiotech（USA）

结论和建议

Global Research Antibodies and Reagents Market size was valued at USD 13.3 billion in 2023 and is poised to grow from USD 14.22 billion in 2024 to USD 24.25 billion by 2032, growing at a CAGR of 6.9% during the forecast period (2025-2032).

The research antibodies and reagents market is on an upward trajectory, driven by the growing demand for high-quality antibodies essential for reproducible research. Key growth factors include the expansion of proteomics and genomics, increased R&D activities aimed at enhancing diagnostic and therapeutic outcomes, and strengthened collaborations between industry and academia. Additionally, rising investments from both profit and non-profit organizations, a focus on biomarker discovery, and government support are bolstering market growth. The shift towards personalized medicine and protein therapeutics further presents lucrative opportunities. However, challenges such as the time-consuming nature of antibody development and pricing pressures may impede progress, alongside emerging concerns over quality and reproducibility that need to be addressed during the forecast period.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Research Antibodies And Reagents market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Research Antibodies And Reagents Market Segments Analysis

Global Research Antibodies and Reagents Market is segmented by Type, Application, Research Area, End User, Distribution Channel and region. Based on Type, the market is segmented into Antibodies and Reagents. Based on Application, the market is segmented into Enzyme-Linked Immunosorbent Assay, Western Blotting, Immunohistochemistry, Flow Cytometry, Polymerase Chain Reaction and Others. Based on Research Area, the market is segmented into Immunology, Cell & Molecular Biology, Neuroscience, Genomics & Proteomics, Biotechnology & Drug Discovery, Microbiology and Others. Based on End User, the market is segmented into Pharmaceutical and Biopharmaceutical Manufacturers, Academic And Research Institutes, Contract Research Organizations (CROs), Hospitals & Diagnostic Laboratories and Others. Based on Distribution Channel, the market is segmented into Direct Sales, Third Party Sales and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Research Antibodies And Reagents Market

The Global Research Antibodies and Reagents market is significantly influenced by the synergy between academic institutions and the research and development sectors of various businesses. This collaboration facilitates the transfer of knowledge and advancements in technology, enhancing innovation and research capabilities. As economic uncertainties rise and technological advancements accelerate, these partnerships have become increasingly prevalent. Market players are focusing on engaging with academic institutions to raise awareness among students and researchers about cutting-edge analytical technologies, reflecting the diverse applications of research-specific antibodies and reagents, which ultimately drives market growth and development.

Restraints in the Global Research Antibodies And Reagents Market

The Global Research Antibodies and Reagents market faces significant challenges due to the reproducibility crisis, which highlights the troubling realization that many findings in biomedical research fail to replicate, casting doubt on their validity. This issue primarily stems from inconsistencies in the quality of antibodies, largely arising from diverse production techniques. Furthermore, the absence of standardized definitions for reproducibility across antibody products and a lack of comprehensive validation standards exacerbate the problem. As a result, researchers encounter difficulties in obtaining reliable and consistent results, which can undermine trust in scientific conclusions drawn from these studies.

Market Trends of the Global Research Antibodies And Reagents Market

The Global Research Antibodies and Reagents market is poised for substantial growth as personalized medicine continues to revolutionize disease detection, categorization, and treatment-especially in oncology. With biopharmaceutical companies ramping up R&D investments in personalized medicine, projected to surge by 33% over the next five years, the demand for advanced antibodies and reagents is escalating. The need for rapid and highly sensitive techniques to analyze proteins and their post-translational modifications is critical for tailoring patient-specific therapies. Researchers are increasingly focusing on gene variants and their correlations with drug responses, underscoring the necessity for innovative tools in this evolving healthcare landscape.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Research Antibodies and Reagents Market Size by Type & CAGR (2025-2032)

• Market Overview
• Antibodies
  • Products
  • Primary Antibodies
  • Secondary Antibodies
  • Source
  • Mouse
  • Rabbit
  • Goat
  • Rat
  • Others
  • Origin
  • Monoclonal Antibodies
  • Polyclonal Antibodies
  • Recombinant Antibodies
• Reagents
  • Buffers & Solution
  • PBS (Phosphate Buffered Saline)
  • Blocking Buffers
  • Dilution Buffers
  • Wash Buffers
  • Chemiluminescent Reagents

Global Research Antibodies and Reagents Market Size by Application & CAGR (2025-2032)

• Market Overview
• Enzyme-Linked Immunosorbent Assay
• Western Blotting
• Immunohistochemistry
• Flow Cytometry
• Polymerase Chain Reaction
• Others

Global Research Antibodies and Reagents Market Size by Research Area & CAGR (2025-2032)

• Market Overview
• Immunology
• Cell & Molecular Biology
• Neuroscience
• Genomics & Proteomics
• Biotechnology & Drug Discovery
• Microbiology
• Others

Global Research Antibodies and Reagents Market Size by End User & CAGR (2025-2032)

• Market Overview
• Pharmaceutical and Biopharmaceutical Manufacturers
• Academic And Research Institutes
• Contract Research Organizations (CROs)
• Hospitals & Diagnostic Laboratories
• Others

Global Research Antibodies and Reagents Market Size by Distribution Channel & CAGR (2025-2032)

• Market Overview
• Direct Sales
• Third Party Sales
• Others

Global Research Antibodies and Reagents Market Size & CAGR (2025-2032)

• North America (Type, Application, Research Area, End User, Distribution Channel)
  • US
  • Canada
• Europe (Type, Application, Research Area, End User, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Application, Research Area, End User, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Application, Research Area, End User, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Application, Research Area, End User, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Thermo Fisher Scientific, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abcam plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cell Signaling Technology, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Techne Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Proteintech Group, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jackson Immuno Research Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GenScript Biotech Corporation (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group Ltd. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Santa Cruz Biotechnology, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Revvity (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Atlas Antibodies AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SouthernBiotech (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations